AB-610

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAB-610
Drug Alias NameAB-610
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 3 kinase gamma inhibitors
TargetsPhosphatidylinositol-4,5-Bisphosphate 3 kinase gamma
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArcus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcus Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A